½ÃÀ庸°í¼­
»óǰÄÚµå
1271287

¼¼°èÀÇ ¿äµµÇùÂø Ä¡·á ½ÃÀå : À¯Çüº°, Ä¡·á¹ýº°(¿äµµ È®Àå¼ú, Á÷ÇÏ ¿äµµ Àý°³¼ú, ¿äµµ ¼ºÇü¼ú, ±âŸ), Áúº´ ÀûÀÀÁõº°, ÃÖÁ¾ »ç¿ëÀÚº°, Áö¿ªº° - ±Ô¸ð, Á¡À¯À², Àü¸Á, ±âȸ ºÐ¼®(2023-2030³â)

Urethral Stricture Treatment Market, By Type, By Treatment (Urethral Dilation, Direct Vision Internal Urethrotomy, Urethroplasty, Others), By Disease Indication, By End User, By Region - Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Coherent Market Insights | ÆäÀÌÁö Á¤º¸: ¿µ¹® | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¿äµµÇùÂøÀº °¨¿°À̳ª ºÎ»óÀ¸·Î ÀÎÇÑ ÈäÅÍ·Î ÀÎÇØ ¿äµµÀÇ ±¸°æÀÌ Á¼¾ÆÁö´Â °ÍÀ» ¸»ÇÕ´Ï´Ù. ¿äµµ ÇùÂøÀº ÈÄ¹æ ¿äµµ ÇùÂø°ú Àü¹æ ¿äµµ ÇùÂøÀÇ µÎ °¡Áö À¯ÇüÀÌ ÀÖ½À´Ï´Ù. ÈÄ¹æ ¿äµµ ÇùÂøÀº ÈÄ¹æ ¿äµµÀÇ ¼¶À¯È­, ¿Ü»óÀ̳ª °ñ¹Ý °ñÀý·Î ÀÎÇÑ Å¸¹Ú»óÀ¸·Î ÀÎÇØ ¹ß»ýÇÕ´Ï´Ù. Àü¹æ ¿äµµ ÇùÂøÀº °¡Àå ÈçÇÏ°Ô ¹ß»ýÇÏ´Â ÇùÂøÀ¸·Î, °¨¿°À̳ª ¿Ü»óÀ¸·Î ÀÎÇÑ ÇØ¸éü ¼¶À¯È­·Î ÀÎÇØ ¹ß»ýÇÕ´Ï´Ù. ÀÌ Áõ»óÀº ¿äµµÁ÷Çϳ»¿äµµÀý°³¼ú(DVIU), ¿äµµ ¼ºÇü¼ú µî ´Ù¾çÇÑ Ä¡·á¹ýÀ¸·Î Ä¡·áÇÒ ¼ö ÀÖ½À´Ï´Ù. ¿äµµÇùÂøÀÇ ÁÖ¿ä Áõ»óÀº ¹è´¢ Àå¾Ö ¹× ÀÚ±Ø, ¹è´¢ ½Ã°£ Áõ°¡, ¹æ±¤ÀÌ ºñ¾îÀÖ´Â µíÇÑ ºÒ¿ÏÀüÇÑ ´À³¦ÀÔ´Ï´Ù. ¼±Áø±¹ ³²¼ºÀÇ À¯º´·üÀº 0.9%·Î ÃßÁ¤µË´Ï´Ù. Æó¼âÀûÀ̰í ÀÚ±ØÀûÀÎ ¹è´¢ Áõ»óÀ» À¯¹ßÇÏ°í ±Ã±ØÀûÀ¸·Î ½ÅÀå ±â´ÉÀ» ÀúÇϽÃų ¼ö ÀÖ½À´Ï´Ù. ¿äµµ ÇùÂøÀº ºñ´¢±â°ú Áø´Ü ¹× Ä¡·á ÀýÂ÷·Î ÀÎÇØ ¹ß»ýÇÒ ¼ö ÀÖ½À´Ï´Ù. °í·ÉÈ­ »çȸ°¡ µµ·¡ÇÔ¿¡ µû¶ó ÀÌ·¯ÇÑ ½Ã¼úÀÌ ´õ¿í º¸ÆíÈ­µÇ°í ÀÖÀ¸¸ç, µû¶ó¼­ ¿äµµ ÇùÂøÁõµµ ´õ¿í º¸ÆíÈ­µÉ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù.

½ÃÀå ¿ªÇÐ

Á¦Ç° Æ÷Æ®Æú¸®¿À¸¦ È®´ëÇϱâ À§ÇØ ½ÃÀå¿¡¼­ ±ÔÁ¦ ´ç±¹ÀÇ ½ÂÀΰú °°Àº ¹«±âÀûÀÎ ¼ºÀå Àü·«ÀÇ Ã¤ÅÃÀÌ Áõ°¡Çϰí ÀÖÀ¸¸ç, ÀÌ´Â ¿¹Ãø ±â°£ µ¿¾È ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¿¹¸¦ µé¾î, 2022³â 1¿ù ºñ´¢±â°ú, ºÎÀΰú µîÀÇ Á¦Ç°À» Á¦°øÇÏ´Â ÀÇ·á ±â¼ú ±â¾÷ÀÎ Laborie.´Â ¿äµµ ¾à¹° ÄÚÆÃ Ç³¼±(DCB)ÀÎ OptilumeÀÇ ¶óÀ̼±½º¸¦ ȹµæÇÏ°í ¹Ì±¹ ½ÄǰÀǾ౹(FDA)À¸·ÎºÎÅÍ Á¦Ç° ½ÂÀÎÀ» ¹Þ¾Ò´Ù°í ¹ßÇ¥Çß½À´Ï´Ù.

º» Á¶»çÀÇ ÁÖ¿ä Æ¯Â¡

  • ÀÌ º¸°í¼­´Â 2022³âÀ» ±âÁØ¿¬µµ·Î ÇÏ¿© ¿¹Ãø ±â°£(2023-2030³â) ½ÃÀå ±Ô¸ð¿Í ¿¬Æò±Õ ¼ºÀå·ü(CAGR%)À» Á¦½ÃÇÏ´Â ¼¼°è ¿äµµÇùÂø Ä¡·áÁ¦ ½ÃÀåÀ» »ó¼¼È÷ ºÐ¼®Çß½À´Ï´Ù.
  • ´Ù¾çÇÑ ºÎ¹®ÀÇ ÀáÀçÀû ¼öÀÍ ±âȸ¸¦ ÆÄ¾ÇÇϰí ÀÌ ½ÃÀå¿¡ ´ëÇÑ ¸Å·ÂÀûÀÎ ÅõÀÚ Á¦¾È ¸ÅÆ®¸¯½º¸¦ ¼³¸íÇÕ´Ï´Ù.
  • ¶ÇÇÑ ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ, ¾ïÁ¦¿äÀÎ, ±âȸ, ½ÅÁ¦Ç° Ãâ½Ã ¶Ç´Â ½ÂÀÎ, ½ÃÀå µ¿Çâ, Áö¿ª Àü¸Á ¹× ÁÖ¿ä ±â¾÷ÀÌ Ã¤ÅÃÇÑ °æÀï Àü·«¿¡ ´ëÇÑ Áß¿äÇÑ °í·Á »çÇ×À» Á¦°øÇÕ´Ï´Ù.
  • ÀÌ º¸°í¼­´Â ±â¾÷ ÇÏÀ̶óÀÌÆ®, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÁÖ¿ä ÇÏÀ̶óÀÌÆ®, À繫 ¼º°ú, Àü·« µîÀÇ ¸Å°³ º¯¼ö¸¦ ±â¹ÝÀ¸·Î ¿äµµÇùÂø Ä¡·á ¼¼°è ½ÃÀå ³» ÁÖ¿ä ±â¾÷ ÇÁ·ÎÆÄÀÏÀ» Á¦°øÇÕ´Ï´Ù.
  • ÀÌ ¿¬±¸ÀÇ ÀϺηΠ´Ù·ïÁö´Â ÁÖ¿ä ±â¾÷Àº Becton, Dickinson and Company, Amecath, Zhejiang Chuangxiang, Medical Technology Co., Cook Group, Taewoong Medical Co., Ltd., Teleflex Incorporated, B. Braun Melsungen AG, Coloplast A/S, Boston Scientific Corporation, Pnn Medical A/ÀÌ º¸°í¼­ÀÇ ÀλçÀÌÆ®¸¦ ÅëÇØ ¸¶ÄÉÅÍ¿Í ±â¾÷ÀÇ °æ¿µÁøÀº ÇâÈÄ Á¦Ç° Ãâ½Ã, Á¦Ç° À¯ÇüÈ­, Á¦Ç° °³¹ß ¹× ¸¶ÄÉÆÃ¿¡ ´ëÇÑ ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖÀ» °ÍÀ¸·Î ±â´ëµË´Ï´Ù. ÇâÈÄ Á¦Ç° Ãâ½Ã, À¯Çü ¾÷±×·¹À̵å, ½ÃÀå È®´ë ¹× ¸¶ÄÉÆÃ Àü·«¿¡ ´ëÇÑ Á¤º¸¿¡ ÀÔ°¢ÇÑ ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖÀ» °ÍÀ¸·Î ±â´ëµË´Ï´Ù.
  • ¿äµµ ÇùÂøÁõ Ä¡·á ¼¼°è ½ÃÀå º¸°í¼­´Â ÅõÀÚÀÚ, °ø±Þ¾÷ü, Á¦Ç° Á¦Á¶¾÷ü, À¯Åë ¾÷ü, ½Å±Ô ÁøÃâ±â¾÷, À繫 ºÐ¼®°¡ µî ÀÌ ¾÷°èÀÇ ´Ù¾çÇÑ ÀÌÇØ °ü°èÀÚ¿¡°Ô ÇØ´çµË´Ï´Ù.
  • ÀÌÇØ°ü°èÀÚ´Â ¼¼°è ¿äµµÇùÂø Ä¡·á ½ÃÀå ºÐ¼®¿¡ »ç¿ëµÇ´Â ´Ù¾çÇÑ Àü·« ¸ÅÆ®¸¯½º¸¦ ÅëÇØ ÀÇ»ç°áÁ¤À» ¿ëÀÌÇÏ°Ô ÇÒ ¼ö ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¸ñÀû°ú ÀüÁ¦Á¶°Ç

  • Á¶»ç ¸ñÀû
  • ÀüÁ¦Á¶°Ç
  • ¾à¾î

Á¦2Àå ½ÃÀå Àü¸Á

  • º¸°í¼­ °³¿ä
    • ½ÃÀå Á¤ÀÇ¿Í ¹üÀ§
  • ÁÖ¿ä ¿ä¾à
    • ½ÃÀå ÇöȲ : À¯Çüº°
    • ½ÃÀå ÇöȲ : Ä¡·á¹ýº°
    • ½ÃÀå ÇöȲ : Áúȯ ÀûÀÀÁõº°
    • ½ÃÀå ÇöȲ : ÃÖÁ¾»ç¿ëÀÚº°
    • ½ÃÀå ÇöȲ : Áö¿ªº°
  • Coherent Opportunity Map(COM)

Á¦3Àå ½ÃÀå ¿ªÇÐ, ±ÔÁ¦, µ¿Ç⠺м®

  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
    • ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ½ÃÀå ±âȸ
    • ¿µÇ⠺м®
    • ÁÖ¿ä ÇÏÀ̶óÀÌÆ®
    • Á¦Ç° ¹ß¸Å
    • ±â¼úÀû Áøº¸
    • PEST ºÐ¼®
    • ¹ý±ÔÁ¦ ½Ã³ª¸®¿À
    • ÀμöÇÕº´(M&A)

Á¦4Àå ¼¼°èÀÇ ¿äµµÇùÂø Ä¡·á ½ÃÀå - Äڷγª¹ÙÀÌ·¯½º(COVID-19) ÆÒµ¥¹ÍÀÇ ¿µÇâ

  • °æÁ¦Àû ¿µÇâ
  • COVID-19 ¿ªÇп¡ ´ëÇØ
  • ¼ö±Þ¿¡ ´ëÇÑ ¿µÇâ

Á¦5Àå ¼¼°èÀÇ ¿äµµÇùÂø Ä¡·á ½ÃÀå, À¯Çüº°, 2017³â-2030³â

  • ÈÄ¹æ ¿äµµÇùÂø
  • Àü¹æ ¿äµµÇùÂø

Á¦6Àå ¼¼°èÀÇ ¿äµµÇùÂø Ä¡·á ½ÃÀå, Ä¡·á¹ýº°, 2017³â-2030³â

  • ¿äµµ È®Àå¼ú
  • Á÷ÇÏ ¿äµµ Àý°³¼ú(DVIU)
  • ¿äµµ ¼ºÇü¼ú
  • ¹®ÇÕ ¿äµµ ¼ºÇü¼ú
  • ġȯ ¿äµµ ¼ºÇü¼ú
  • ±âŸ

Á¦7Àå ¼¼°èÀÇ ¿äµµÇùÂø Ä¡·á ½ÃÀå, Áúȯ ÀûÀÀº°, 2017³â-2030³â

  • ÀÇ¿ø¼º
  • Ư¹ß¼º
  • °¨¿°Áõ À¯·¡
  • ¿Ü»ó
  • ±âŸ

Á¦8Àå ¼¼°èÀÇ ¿äµµÇùÂø Ä¡·á ½ÃÀå : ÃÖÁ¾»ç¿ëÀÚº°, 2017³â-2030³â

  • º´¿ø
  • ¿Ü·¡¼ö¼ú¼¾ÅÍ(ASC)
  • ±âŸ

Á¦9Àå ¼¼°èÀÇ ¿äµµÇùÂø Ä¡·á ½ÃÀå : Áö¿ªº°, 2017³â-2030³â

  • ºÏ¹Ì
  • ¹Ì±¹
  • ij³ª´Ù
  • ¶óƾ¾Æ¸Þ¸®Ä«
  • ºê¶óÁú
  • ¸ß½ÃÄÚ
  • ¾Æ¸£ÇîÆ¼³ª
  • ±âŸ ¶óƾ¾Æ¸Þ¸®Ä«
  • À¯·´
  • ¿µ±¹
  • µ¶ÀÏ
  • ÀÌÅ»¸®¾Æ
  • ÇÁ¶û½º
  • ½ºÆäÀÎ
  • ·¯½Ã¾Æ
  • ±âŸ À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
  • Áß±¹
  • Àεµ
  • ÀϺ»
  • ASEAN
  • È£ÁÖ
  • Çѱ¹
  • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
  • Áßµ¿
  • GCC
  • À̽º¶ó¿¤
  • ±âŸ Áßµ¿
  • ¾ÆÇÁ¸®Ä«
  • ºÏ¾ÆÇÁ¸®Ä«
  • Áß¾Ó¾ÆÇÁ¸®Ä«
  • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹

Á¦10Àå °æÀï ±¸µµ

  • Becton, Dickinson and Company
  • Amecath
  • Zhejiang Chuangxiang Medical Technology Co., Ltd
  • Allium Ltd.
  • SURGIMEDIK
  • Cook Group
  • Teawoong Medical Co., Ltd.
  • Teleflex Incorporated
  • B. Braun Melsungen AG
  • Coloplast A/S
  • Boston Scientific Corporation
  • Pnn Medical A/S
  • Laborie.

Á¦11Àå ¼½¼Ç

  • Á¶»ç ¹æ¹ý¿¡ ´ëÇØ
  • ÃâÆÇ»ç¿¡ ´ëÇØ
LSH 23.05.26

Urethral stricture is the narrowing of the calibre of the urethra that is caused due to scarring resulting from infection or injury. There are two types of urethral strictures named posterior urethral stricture and anterior urethral stricture. Posterior urethral strictures occur due to fibrosis of the posterior urethra or distraction injuries that result from trauma or pelvic fractures. Anterior urethral stricture are the most commonly occurring strictures, and are caused due to infection or trauma leading to spongiofibrosis. The condition can be treated with various treatment options such as urethral direct vision internal urethrotomy (DVIU), urethroplasty, and other treatments. The main symptoms of urethral stricture are obstructed and irritated micturition, with increased urination time, and a feeling of incomplete bladder emptying. Its prevalence among men in industrial countries is estimated at 0.9%. It produces obstructive and irritative urinary symptoms, and can ultimately impair renal function. Urethral strictures can be caused by diagnostic or therapeutic urological procedures. These procedures are being performed more commonly, because the population is aging, and thus, urethral strictures will probably become more common as well.

Market Dynamics

Increasing adoption of inorganic growth strategies such as approvals by the regulatory authorities in the market to expand their product portfolio, is expected to drive the market growth over the forecast period. For instance, in January 2022, Laborie., a medical technology company thath provide products for urology, gynecology, and others, announced that it has received a license to the Optilume, a urethral drug coated balloon (DCB), laborite., and product is approved from U.S. Food and Drug Administration (FDA).

Key features of the study:

  • This report provides in-depth analysis of the global urethral stricture treatment market, and provides market size (US$ Million) and Compound Annual Growth Rate (CAGR%) for the forecast period (2023-2030), considering 2022 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global urethral stricture treatment market based on the following parameters-company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study are Becton, Dickinson and Company, Amecath, Zhejiang Chuangxiang, Medical Technology Co., Ltd, Allium Ltd., SURGIMEDIK, Cook Group, Taewoong Medical Co., Ltd., Teleflex Incorporated, B. Braun Melsungen AG, Coloplast A/S, Boston Scientific Corporation, and Pnn Medical A/S. , and Laborie.Insights from this report will allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • Global urethral stricture treatrment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global urethral stricture treatment market

Detailed Segmentation:

  • Global Urethral Stricture Treatment Market, By Type:
    • Posterior Urethral Stricture
    • Anterior Urethral Stricture
  • Global Urethral Stricture Treatment Market, By Treatment:
    • Urethral Dilation
    • Direct Vision Internal Urethrotomy (DVIU)
    • Urethroplasty
      • Anastomotic Urethroplasty
      • Substitution Urethroplasty
    • Others
  • Global Urethral Stricture Treatment Market, By Disease Indication:
    • Latrogenic
    • Idiopathic
    • Infection-induced
    • Trauma
    • Others
  • Global Urethral Stricture Treatment Market, By End User:
    • Hospitals
    • Ambulatory Surgical Centers
    • Others
  • Global Urethral Stricture Treatment Market, By Region:
    • North America
      • By Country:
    • U.S.
    • Canada
    • Latin America
      • By Country:
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
    • Europe
      • By Country:
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
    • Asia Pacific
      • By Country
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
    • Middle East
      • By Country:
    • GCC
    • Israel
    • Rest of Middle East
    • Africa
      • By Country/Region:
    • South Africa
    • Central Africa
    • North Africa
  • Company Profiles
    • Becton, Dickinson and Company*
      • Company Highlights
      • Products Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Amecath
    • Zhejiang Chuangxiang
    • Medical Technology Co., Ltd
    • Koninklijke Philips N.V.
    • Allium Ltd.
    • SURGIMEDIK
    • Cook Group
    • Taewoong Medical Co., Ltd.
    • Teleflex Incorporated
    • Braun Melsungen AG
    • Coloplast A/S
    • Boston Scientific Corporation
    • Pnn Medical A/S

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Type
    • Market Snapshot, By Treatment
    • Market Snapshot, By Disease Indication
    • Market Snapshot, By End User
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
    • Impact Analysis
    • Key Highlights
    • Product Launches
    • Technological Advancements
    • PEST Analysis
    • Regulatory Scenario
    • Mergers and Acquisitions

4. Global Urethral Stricture Treatment Market- Impact of Coronavirus (Covid-19) Pandemic

  • Economic Impact
  • COVID-19 Epidemiology
  • Impact on Supply and Demand

5. Global Urethral Stricture Treatment Market, By Type, 2017-2030, (US$ Million)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2017 - 2030
    • Segment Trends
  • Posterior Urethral Stricture
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Anterior Urethral Stricture
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

6. Global Urethral Stricture Treatment Market, By Treatment, 2017 - 2030, (US$ Million)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2017 - 2030
    • Segment Trends
  • Urethral Dilation
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Direct Vision Internal Urethrotomy (DVIU)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Urethroplasty
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Anastomotic Urethroplasty
    • Introduction
    • Market Size and Forecast, and Y-O-Y Growth, 2017-2030, (US$ Million)
  • Substitution Urethroplasty
    • Introduction
    • Market Size and Forecast, and Y-O-Y Growth, 2017-2030, (US$ Million)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-O-Y Growth, 2017-2030, (US$ Million)

7. Global Urethral Stricture Treatment Market, By Disease Indication, 2017 - 2030, (US$ Million)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2017 - 2030
    • Segments Trends
  • Latrogenic
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Idiopathic
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Infection-induced
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Trauma
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-O-Y Growth, 2017-2030, (US$ Million)

8. Global Urethral Stricture Treatment Market, By End User, 2017 - 2030, (US$ Million)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-O-Y Growth analysis, 2017 - 2030
    • Segment Trends
  • Hospitals
    • Introduction
    • Market Size and Forecast, and Y-O-Y Growth, 2017 - 2030, (US$) Million)
  • Ambulatory Surgical Centers
    • Introduction
    • Market Size and Forecast, and Y-O-Y Growth, 2017 - 2030, (US$) Million)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-O-Y Growth, 2017 - 2030, (US$) Million)

9. Global Urethral Stricture Treatment Market, By Region, 2017 - 2030, (US$ Million)

  • Introduction
    • Market Share Analysis, By Region, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, For Region, 2017-2030
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
  • U.S.
  • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
  • U.K.
  • Germany
  • Italy
  • France
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
  • China
  • India
  • Japan
  • ASEAN
  • Australia
  • South Korea
  • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2017 - 2030, (US$ Million)
  • North Africa
  • Central Africa
  • South Africa

10. Competitive Landscape

  • Becton, Dickinson and Company
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Amecath
  • Zhejiang Chuangxiang Medical Technology Co., Ltd
  • Allium Ltd.
  • SURGIMEDIK
  • Cook Group
  • Teawoong Medical Co., Ltd.
  • Teleflex Incorporated
  • B. Braun Melsungen AG
  • Coloplast A/S
  • Boston Scientific Corporation
  • Pnn Medical A/S
  • Laborie.

11. Section

  • Research Methodology
  • About Us
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦